HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
2.680
-0.245 (-8.38%)
At close: Aug 14, 2026, 4:00 PM EDT
2.700
+0.020 (0.75%)
After-hours: Aug 14, 2026, 7:37 PM EDT
HCW Biologics Employees
HCW Biologics had 35 employees as of December 31, 2025. The number of employees decreased by 1 or -2.78% compared to the previous year.
Employees
35
Change (1Y)
-1
Growth (1Y)
-2.78%
Revenue / Employee
$192,034
Profits / Employee
-$611,719
Market Cap
3.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | -1 | -2.78% |
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 33 |
| Curis | 24 |
| Moleculin Biotech | 17 |
| TransCode Therapeutics | 12 |
| Galmed Pharmaceuticals | 6 |
| Jupiter Neurosciences | 5 |
| GRI Bio | 4 |
| 60 Degrees Pharmaceuticals | 3 |
HCWB News
- 1 day ago - HCW Biologics Earnings release: Q2 2026 - Filings
- 1 day ago - HCW Biologics Quarterly report: Q2 2026 - Filings
- 1 day ago - HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results - GlobeNewsWire
- 18 days ago - HCW Biologics announces pricing of $1.6M private placement - TheFly
- 18 days ago - HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering - GlobeNewsWire
- 24 days ago - HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027 - GlobeNewsWire
- 6 weeks ago - HCW Biologics regains compliance with Nasdaq - TheFly
- 6 weeks ago - HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter - GlobeNewsWire